Moderna's Omicron-targeting vaccines meet endpoint in Phase II/III trial
Moderna Is Developing Two Different Omicron-Targeting Booster Shots - WSJ
Moderna on X: "A Phase 2/3 trial for mRNA-1273.222 is currently underway. We have rapidly scaled manufacturing of mRNA-1273.222 to be ready, if authorized, to deliver doses in September. https://t.co/AQG4hfwNe6" / X
Moderna's BA.4/BA.5 Targeting Bivalent Booster, mRNA-1273.222, Meets Primary Endpoint of Superiority Against Omicron Variants Compared to Booster Dose of mRNA-1273 in Phase 2/3 Clinical Trial
Covid Booster: US to Buy $1.7 Billion of Moderna Omicron-Specific Vaccine (MRNA) - Bloomberg
FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Booster Doses - Pharmacy Practice News
dinero.com.sv - Moderna receives FDA clearance for emergency use of booster vaccine
Moderna completes FDA filing for bivalent COVID-19 booster vaccine, MR
Moderna on X: "In a Phase 2/3 trial in over 500 adults, mRNA-1273.222, induced significantly higher neutralizing antibody titers against BA.4/BA.5 compared to a booster dose of mRNA-1273. Read more: https://t.co/CPnxL03nZW https://t.co/ODihw6qtsQ" /
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results | Nature Medicine
With 34 Vaccine Programs in Development, Moderna Eyes Global Launches | BioSpace
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice | Nature Medicine
EMA CHMP recommends Moderna's Covid-19 booster for children
Omicron-tailored shots show better response than original COVID vaccine: Moderna | Mint
Moderna: New booster protects better against variants - The Jerusalem Post
Moderna xin cấp phép vaccine ngừa Omicron cho thanh thiếu niên, trẻ nhỏ tại Mỹ | VTV.VN
Moderna on X: "We have submitted a request for emergency use authorization (EUA) for our Omicron-targeting bivalent #COVID19 #vaccine, mRNA-1273.222, in children and adolescents 12 to 17 years of age to the
Moderna COVID19 Bivalent vaccine (Original and Omicron BA.4/BA.5)